title: Investigational drugs for eating disorders.
abstract: The eating disorders anorexia nervosa, bulimia nervosa and binge eating disorder are common, significant public health problems which are treated with nutritional, psychotherapeutic and pharmacological interventions. A number of drugs (mostly antidepressant drugs) are currently used in their treatment to some benefit, but there is substantial room for improvement. A wide variety of compounds are listed as under investigation for the treatment of eating disorders. They have a diverse variety of mechanisms of action, reflecting the complex nature of the control of food intake. While none of these compounds are close to release at present, the diversity of mechanisms under study lend some optimism that more effective approaches will be identified.
authors.affiliation: Department of Psychiatry, University of Minnesota Medical School, F282/2A West, 2450 Riverside Avenue, Minneapolis, Minnesota 55454, USA. crowx002@umn.edu
authors.forename: Scott
authors.initials: S
authors.lastname: Crow
authors.forename: Eric
authors.initials: E
authors.lastname: Brown
mesh_terms: D000856:Anorexia Nervosa / Q000188:drug therapy* / Q000453:epidemiology; D002032:Bulimia / Q000188:drug therapy* / Q000453:epidemiology; D002986:Clinical Trials as Topic; D015507:Drugs, Investigational / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans
chemical_list: D015507:Drugs, Investigational